文献速递类风湿关节炎脊柱关节炎

经动脉关节周围栓塞术(TAPE)治疗炎症性风湿性单关节炎:一项概念验证研究

TAPE in inflammatory rheumatic monoarthritis: a proof-of-concept study.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

该概念验证研究评估了经动脉关节周围栓塞术(TAPE)在炎症性风湿性单关节炎中的可行性、安全性和临床效果,并与膝骨关节炎(OA)患者进行比较。结果显示TAPE技术成功率高、无不良事件,疼痛显著降低,炎症病例影像学显示滑膜炎和关节积液减少。

要点

  • TAPE在炎症性风湿性单关节炎中技术可行、安全且耐受良好。
  • TAPE与临床有意义的疼痛减轻相关,膝OA与炎症性风湿病疼痛改善相当。
  • 影像学显示炎症病例滑膜炎和关节积液减少,需更大规模前瞻性研究验证。

核心结论

  • TAPE是治疗难治性炎症性风湿性单关节炎可行、安全且耐受良好的方法,与临床有意义的疼痛减轻相关。

研究设计与样本

  • TAPE使用临时栓塞剂亚胺培南/西司他丁进行,治疗关节包括膝、踝和一个桡腕关节。

主要发现

  • 中位VAS评分从基线5.0(IQR 3.00-6.00)降至术后第1天1.0(IQR 0.0-3.0)和第90天1.0(IQR 0.00-4.25)。
  • 膝OA与炎症性风湿病关节的疼痛减轻程度相当。
  • 70.6%患者关节周围周长减少,58.8%患者关节活动度改善。
  • 炎症病例影像学显示滑膜炎和关节积液减少。
  • TAPE在所有患者中技术成功,无不良事件发生。

临床怎么用

  • 对于关节腔内及全身DMARDs治疗无效的炎症性风湿性单关节炎患者,TAPE可作为可行的微创治疗选择。
  • TAPE使用亚胺培南/西司他丁作为临时栓塞剂,术后疼痛显著减轻且安全性良好。

局限性

  • 需更大规模前瞻性研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Transarterial periarticular embolization (TAPE) is a minimally invasive endovascular technique established for the treatment of knee osteoarthritis (OA). Its role in inflammatory rheumatic monoarthritis has not yet been investigated. This proof-of-concept study evaluated the feasibility, safety and clinical effects of TAPE in inflammatory rheumatic monoarthritis and compared outcomes with those in knee OA. METHODS: Seventeen joints in 14 patients (7 female, 7 male) were treated, including 11 patients with knee OA and three patients (6 joints) with inflammatory rheumatic joint diseases (rheumatoid arthritis, psoriatic arthritis, or spondyloarthritis) refractory to intra-articular and systemic therapy with disease-modifying antirheumatic drugs (DMARDs). TAPE was performed using the temporary embolic agent imipenem/cilastatin. Treated joints included knees, ankles and one radiocarpal joint. Pain was assessed using the visual analogue scale (VAS). Safety outcomes, periarticular circumference and joint range of motion were evaluated, with ultrasound and MRI follow-up performed in a subset of patients. RESULTS: Median VAS scores decreased from 5.0 (IQR 3.00-6.00) at baseline to 1.0 (IQR 0.0-3.0) at day 1 and 1.0 (IQR 0.00-4.25) at day 90 post TAPE. Comparable pain reduction was observed in knee OA and inflammatory rheumatic joint disease. Reduced periarticular circumference was observed in 70.6% and improved joint range of motion in 58.8% of patients. Imaging demonstrated reduced synovitis and joint effusion in inflammatory cases. TAPE was technically successful in all patients and no adverse events occurred. CONCLUSION: TAPE is a feasible, safe and well-tolerated treatment associated with clinically meaningful pain reduction in therapy-refractory inflammatory rheumatic monoarthritis. Larger prospective studies are warranted.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Pfeil A, Pflug C, Barthel A, et al. TAPE in inflammatory rheumatic monoarthritis: a proof-of-concept study. Rheumatology (Oxford). 2026. PMID: 42633565. doi:10.1093/rheumatology/keag459

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。